• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例罕见的套细胞淋巴瘤样B细胞肿瘤发生t(11;22),导致IGL与CCND1融合:病例报告

A rare case of t(11;22) in a mantle cell lymphoma like B-cell neoplasia resulting in a fusion of IGL and CCND1: case report.

作者信息

Rocha Cristiano Krings, Praulich Inka, Gehrke Iris, Hallek Michael, Kreuzer Karl-Anton

机构信息

Department I of Internal Medicine, University at Cologne, Cologne, Germany.

出版信息

Mol Cytogenet. 2011 Apr 1;4(1):8. doi: 10.1186/1755-8166-4-8.

DOI:10.1186/1755-8166-4-8
PMID:21457541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3077317/
Abstract

The chromosomal translocation (11;14)(q13;q32) rearranging the locus for cyclin D1 (CCND1) to that of the immunoglobulin heavy chain (IGH) can be found in virtually all cases of mantle cell lymphoma (MCL), while other CCND1 translocations are extremely rare. As CCND1 overexpression and activation is a hallmark of MCL it is regarded as a central biological mechanism in the development and maintenance of this disease.Here we present a patient initially diagnosed with chronic lymphocytic leukemia (CLL) where chromosome banding analysis revealed, among other aberrations, a translocation (11;22)(q13;q11.2). We show by fluorescence in situ hybridization (FISH) analysis that on chromosome 22 the immunoglobulin light chain lambda (IGL) is involved in this cytogenetic aberration. Additionally, we demonstrate the resulting overexpression of CCND1 on the RNA and protein level, thereby consolidating the new diagnosis of a MCL-like B-cell neoplasia. Summing up, we described a rare case of t(11;22)(q13;q11.2) in a MCL-like neoplasia and showed that this aberration leads to an overexpression of CCND1 which is regarded as a key biological feature in MCL. This case underlines the importance of cytogenetic analyses especially in atypical cases of B cell lymphomas.

摘要

染色体易位(11;14)(q13;q32),即将细胞周期蛋白D1(CCND1)基因座重排至免疫球蛋白重链(IGH)基因座,几乎在所有套细胞淋巴瘤(MCL)病例中均可发现,而其他CCND1易位则极为罕见。由于CCND1的过表达和激活是MCL的一个标志,它被视为该疾病发生和维持的核心生物学机制。在此,我们报告一名最初被诊断为慢性淋巴细胞白血病(CLL)的患者,染色体带型分析显示,除其他畸变外,存在易位(11;22)(q13;q11.2)。我们通过荧光原位杂交(FISH)分析表明,在22号染色体上,免疫球蛋白轻链λ(IGL)参与了这一细胞遗传学畸变。此外,我们还在RNA和蛋白质水平上证实了由此导致的CCND1过表达,从而巩固了MCL样B细胞肿瘤的新诊断。综上所述,我们描述了一例MCL样肿瘤中罕见的t(11;22)(q13;q11.2)病例,并表明这种畸变导致CCND1过表达,而CCND1过表达被认为是MCL的关键生物学特征。该病例强调了细胞遗传学分析的重要性,尤其是在B细胞淋巴瘤的非典型病例中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/be3be066c13e/1755-8166-4-8-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/b060a3ee32c4/1755-8166-4-8-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/4e0cd379c3cb/1755-8166-4-8-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/31302419e868/1755-8166-4-8-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/676b4b855b77/1755-8166-4-8-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/e723e528027f/1755-8166-4-8-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/d362d1407913/1755-8166-4-8-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/be3be066c13e/1755-8166-4-8-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/b060a3ee32c4/1755-8166-4-8-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/4e0cd379c3cb/1755-8166-4-8-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/31302419e868/1755-8166-4-8-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/676b4b855b77/1755-8166-4-8-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/e723e528027f/1755-8166-4-8-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/d362d1407913/1755-8166-4-8-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73dd/3077317/be3be066c13e/1755-8166-4-8-7.jpg

相似文献

1
A rare case of t(11;22) in a mantle cell lymphoma like B-cell neoplasia resulting in a fusion of IGL and CCND1: case report.一例罕见的套细胞淋巴瘤样B细胞肿瘤发生t(11;22),导致IGL与CCND1融合:病例报告
Mol Cytogenet. 2011 Apr 1;4(1):8. doi: 10.1186/1755-8166-4-8.
2
A case study of t(14;22)(q32;q11) involving immunoglobulin heavy and light chain in follicular lymphoma.滤泡性淋巴瘤中涉及免疫球蛋白重链和轻链的t(14;22)(q32;q11)病例研究。
Int J Clin Exp Pathol. 2018 Jan 1;11(1):448-454. eCollection 2018.
3
Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.在一名IGH-CCND1阴性的套细胞淋巴瘤患者中检测到t(12;14)(p13;q32),该患者类似超高危慢性淋巴细胞白血病。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7494-8. eCollection 2015.
4
Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.应用间期分子细胞遗传学检测套细胞淋巴瘤和非典型慢性淋巴细胞白血病中的t(11;14)
Genes Chromosomes Cancer. 1998 Oct;23(2):175-82. doi: 10.1002/(sici)1098-2264(199810)23:2<175::aid-gcc11>3.0.co;2-n.
5
Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review.伴获得性t(11;14)(q13;q32) CCND1-IGH的慢性粒细胞白血病:一例报告及文献复习
Cancer Genet. 2016 Oct;209(10):481-485. doi: 10.1016/j.cancergen.2016.09.007. Epub 2016 Sep 21.
6
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Secondary Acquisition of t(11;14)(q13;q32)/CCND1-IGH: A Rare Variant Of Richter Transformation to Mantle Cell Lymphoma.伴有继发性获得性t(11;14)(q13;q32)/CCND1-IGH的慢性淋巴细胞白血病/小淋巴细胞淋巴瘤:向套细胞淋巴瘤转化的Richter综合征的罕见变异型
Clin Lymphoma Myeloma Leuk. 2022 May;22(5):e310-e313. doi: 10.1016/j.clml.2021.10.017. Epub 2021 Nov 3.
7
Variant t(2;11)(p11.2;q13) without IGK involvement in a case of mantle cell lymphoma.一例套细胞淋巴瘤中不涉及IGK的变异型t(2;11)(p11.2;q13)
Cancer Genet Cytogenet. 2007 Jun;175(2):154-8. doi: 10.1016/j.cancergencyto.2007.02.012.
8
CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus.伴有CCND2基因与IGL基因座易位的CD5阳性、细胞周期蛋白D1阴性套细胞淋巴瘤
Cancer Genet. 2011 Mar;204(3):162-4. doi: 10.1016/j.cancergencyto.2010.08.016.
9
Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma.荧光原位杂交技术在套细胞淋巴瘤中的诊断效用
Br J Haematol. 2000 Sep;110(4):856-62. doi: 10.1046/j.1365-2141.2000.02303.x.
10
Detection of the t(11;14)(q13;q32) without CCND1/IGH fusion in a case of acute myeloid leukemia.1例急性髓系白血病中未检测到CCND1/IGH融合的t(11;14)(q13;q32)。
Cancer Genet Cytogenet. 2009 Dec;195(2):164-7. doi: 10.1016/j.cancergencyto.2009.08.013.

引用本文的文献

1
SQSTM1/p62 predicts prognosis and upregulates the transcription of CCND1 to promote proliferation in mantle cell lymphoma.SQSTM1/p62可预测套细胞淋巴瘤的预后,并上调CCND1的转录以促进其增殖。
Protoplasma. 2025 May;262(3):635-647. doi: 10.1007/s00709-024-02023-z. Epub 2025 Jan 9.
2
[IGL-CCND1 positive mantle cell lymphoma: a case report and literature review].[IGL-CCND1阳性套细胞淋巴瘤:一例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2023 Jul 14;44(7):598-601. doi: 10.3760/cma.j.issn.0253-2727.2023.07.015.
3
Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell Lymphomas.

本文引用的文献

1
High lymphoid enhancer-binding factor-1 expression is associated with disease progression and poor prognosis in chronic lymphocytic leukemia.高淋巴样增强子结合因子-1表达与慢性淋巴细胞白血病的疾病进展及不良预后相关。
Hematol Rep. 2010 Jan 26;2(1):e3. doi: 10.4081/hr.2010.e3. Epub 2010 May 6.
2
Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping.自动化模式引导的主成分分析与基于专家的 B 细胞慢性淋巴增殖性疾病免疫表型分类:临床免疫表型标准化的重要一步。
Leukemia. 2010 Nov;24(11):1927-33. doi: 10.1038/leu.2010.160. Epub 2010 Sep 16.
3
套细胞淋巴瘤的遗传学、分子诊断工具及治疗的当前知识
Front Oncol. 2021 Nov 23;11:739441. doi: 10.3389/fonc.2021.739441. eCollection 2021.
4
Enhancing B-Cell Malignancies-On Repurposing Enhancer Activity towards Cancer.增强B细胞恶性肿瘤——关于将增强子活性重新用于癌症治疗
Cancers (Basel). 2021 Jun 29;13(13):3270. doi: 10.3390/cancers13133270.
5
BAFF receptor antibody for mantle cell lymphoma therapy.治疗套细胞淋巴瘤的 BAFF 受体抗体。
Oncoimmunology. 2021 Mar 5;10(1):1893501. doi: 10.1080/2162402X.2021.1893501.
6
Truncation of 3' CCND1 by t(11;22) leads to negative SP4 CCND1 immunohistochemistry in blastoid mantle cell lymphoma.t(11;22)导致 3' CCND1 截断,从而使 blastoid 套细胞淋巴瘤的 SP4 CCND1 免疫组化呈阴性。
Blood Adv. 2021 Jan 12;5(1):61-65. doi: 10.1182/bloodadvances.2020003417.
7
Mantle cell lymphoma--a spectrum from indolent to aggressive disease.套细胞淋巴瘤——一种从惰性到侵袭性疾病的谱系。
Virchows Arch. 2016 Mar;468(3):245-57. doi: 10.1007/s00428-015-1840-6. Epub 2015 Aug 23.
Deletion of 5q as a rare abnormality in chronic lymphocytic leukemia.
5q缺失作为慢性淋巴细胞白血病中的一种罕见异常。
Cancer Genet Cytogenet. 2010 Jul 15;200(2):175-9. doi: 10.1016/j.cancergencyto.2010.04.002.
4
Detection of a t(4;14)(p16;q32) in two cases of lymphoma showing both the immunophenotype of chronic lymphocytic leukemia.在两例均表现出慢性淋巴细胞白血病免疫表型的淋巴瘤病例中检测到t(4;14)(p16;q32)。
Cancer Genet Cytogenet. 2010 Jul 15;200(2):170-4. doi: 10.1016/j.cancergencyto.2010.03.009.
5
Cytogenetic investigations of chronic lymphocytic leukemia.慢性淋巴细胞白血病的细胞遗传学研究
Cancer Genet Cytogenet. 2010 Apr 15;198(2):155-61. doi: 10.1016/j.cancergencyto.2009.12.014.
6
Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.145 例套细胞淋巴瘤患者中继发细胞遗传学异常的发生率及其对预后的影响。
Genes Chromosomes Cancer. 2010 May;49(5):439-51. doi: 10.1002/gcc.20754.
7
Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.基因组和基因表达谱分析定义了惰性形式的套细胞淋巴瘤。
Cancer Res. 2010 Feb 15;70(4):1408-18. doi: 10.1158/0008-5472.CAN-09-3419. Epub 2010 Feb 2.
8
Mantle cell lymphoma.套细胞淋巴瘤。
Haematologica. 2009 Nov;94(11):1488-92. doi: 10.3324/haematol.2009.013359.
9
Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected.环磷腺苷依赖性蛋白激酶催化亚基α在慢性髓系白血病中的表达及其临床意义
J Clin Pathol. 2009 Oct;62(10):948-50. doi: 10.1136/jcp.2008.063701.
10
Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR.基于荧光原位杂交和实时定量 PCR 的 cyclin D2+ 套细胞淋巴瘤的鉴别诊断。
Haematologica. 2009 Nov;94(11):1595-8. doi: 10.3324/haematol.2009.010173. Epub 2009 Jul 16.